Physician
North Shore Pathologists SC
North Shore Pathologists SC was paid $2.58M by Medicaid between Jan 2018 and Dec 2024, across 145 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 73% of everything it billed.
33Billing provider infoNORTH SHORE PATHOLOGISTS SC
MILWAUKEE, WI 53211
MILWAUKEE, WI 53211
33aNPI1184703829assigned 11/03/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$2.58M
24GClaims265,284
24DCodes billed145
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Wisconsin
Rank by total paid#2 of 47
Median peer was paid$3K
This provider vs. median994×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,072 | $358K | |
| 2019 | 11,699 | $361K | |
| 2020 | 17,304 | $355K | |
| 2021 | 125,920 | $452K | |
| 2022 | 68,573 | $396K | |
| 2023 | 12,788 | $403K | |
| 2024incomplete | 17,928 | $259K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 73% | 52,761 | 42,319 | $1.89M |
| 88307 | 8.9% | 3,549 | 3,069 | $230K | |
| 88112 | 3.7% | 2,722 | 2,209 | $95K | |
| 88342 | 3.5% | 3,893 | 3,230 | $90K | |
| 88141 | 2.7% | 4,246 | 3,774 | $69K | |
| 83020 | 2.2% | 4,279 | 3,762 | $56K | |
| 85060 | 1.4% | 3,153 | 2,678 | $35K | |
| 88304 | <1% | 2,479 | 2,192 | $21K | |
| 84165 | <1% | 2,090 | 1,784 | $18K | |
| P3001 | Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician | <1% | 629 | 388 | $9K |
| 88189 | <1% | 103 | 79 | $7K | |
| 80053 | Comprehensive metabolic panel | <1% | 18,308 | 15,493 | $5K |
133 more codes
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,560 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,562 | $3K |
| 88312 | <1% | 204 | $3K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 3,943 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 23,176 | $3K |
| 88173 | <1% | 170 | $3K | |
| 87634 | <1% | 499 | $2K | |
| 86334 | <1% | 222 | $2K | |
| 88341 | <1% | 69 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,722 | $2K |
| 85390 | <1% | 149 | $2K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 706 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,810 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 888 | $2K |
| 81025 | <1% | 6,063 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 9,695 | $1K |
| 85027 | <1% | 5,937 | $1K | |
| 83880 | <1% | 817 | $997.19 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,034 | $964.35 |
| 83735 | <1% | 4,768 | $880.56 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,548 | $845.16 |
| 84145 | <1% | 217 | $810.81 | |
| 86850 | <1% | 2,092 | $692.90 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 846 | $571.61 |
| 86780 | <1% | 2,163 | $549.99 | |
| 36416 | <1% | 761 | $523.97 | |
| 86803 | <1% | 1,187 | $455.77 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 228 | $450.00 |
| 80061 | Lipid panel | <1% | 4,289 | $439.63 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,045 | $435.76 |
| 87040 | <1% | 718 | $374.85 | |
| 80143 | <1% | 1,219 | $347.56 | |
| 84484 | <1% | 3,976 | $337.34 | |
| 86481 | <1% | 112 | $321.66 | |
| 86900 | <1% | 2,254 | $300.05 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,772 | $288.65 |
| 82728 | <1% | 1,261 | $270.64 | |
| 83605 | <1% | 1,335 | $269.94 | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | <1% | 14 | $262.32 |
| 84703 | <1% | 1,160 | $249.66 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 123 | $243.87 |
| 87081 | <1% | 2,253 | $223.40 | |
| 84132 | <1% | 1,035 | $216.18 | |
| 82607 | <1% | 1,249 | $213.50 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 387 | $210.54 |
| 84702 | <1% | 1,399 | $206.81 | |
| 87340 | <1% | 752 | $205.82 | |
| 80306 | <1% | 733 | $201.98 | |
| 81001 | <1% | 8,153 | $201.43 | |
| 83690 | <1% | 3,929 | $196.20 | |
| 82805 | <1% | 74 | $189.08 | |
| 86901 | <1% | 2,326 | $184.03 | |
| 85610 | <1% | 2,838 | $179.08 | |
| 84166 | <1% | 16 | $169.60 | |
| 86762 | <1% | 484 | $168.96 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,039 | $168.48 |
| 82746 | <1% | 566 | $168.48 | |
| 84550 | <1% | 689 | $168.25 | |
| 84450 | <1% | 436 | $162.66 | |
| 83615 | <1% | 694 | $155.84 | |
| 82570 | <1% | 814 | $152.02 | |
| 82565 | <1% | 1,095 | $148.84 | |
| 82951 | <1% | 212 | $143.98 | |
| 84460 | <1% | 442 | $133.60 | |
| 87807 | <1% | 41 | $131.00 | |
| 84100 | <1% | 809 | $129.87 | |
| 87653 | <1% | 290 | $122.18 | |
| 87147 | <1% | 607 | $121.14 | |
| 87210 | <1% | 1,340 | $116.20 | |
| 85730 | <1% | 1,119 | $114.60 | |
| 82550 | <1% | 560 | $104.72 | |
| 87186 | <1% | 617 | $100.63 | |
| 80179 | <1% | 1,191 | $95.04 | |
| 88300 | <1% | 26 | $89.16 | |
| 83550 | <1% | 691 | $84.54 | |
| 85379 | <1% | 1,201 | $82.83 | |
| 87077 | <1% | 445 | $81.05 | |
| 81003 | <1% | 3,715 | $79.21 | |
| 87070 | <1% | 723 | $72.52 | |
| 84153 | <1% | 171 | $70.80 | |
| 85049 | <1% | 408 | $66.30 | |
| 82010 | <1% | 81 | $64.45 | |
| 82800 | <1% | 175 | $63.80 | |
| 87205 | <1% | 412 | $63.40 | |
| 83540 | <1% | 750 | $62.61 | |
| 80500 | <1% | 37 | $61.60 | |
| 86140 | <1% | 1,035 | $59.40 | |
| 80076 | <1% | 511 | $58.55 | |
| 82950 | <1% | 449 | $52.25 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 109 | $48.16 |
| 82077 | <1% | 955 | $41.46 | |
| 82947 | <1% | 302 | $39.30 | |
| 84439 | <1% | 744 | $38.35 | |
| 84520 | <1% | 295 | $38.35 | |
| 87075 | <1% | 220 | $28.08 | |
| 82140 | <1% | 13 | $21.60 | |
| 83721 | <1% | 27 | $21.00 | |
| 82330 | <1% | 72 | $20.26 | |
| 85014 | <1% | 654 | $17.64 | |
| 84156 | <1% | 222 | $16.45 | |
| 82962 | <1% | 1,259 | $15.95 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,024 | $13.86 |
| 83655 | <1% | 495 | $12.11 | |
| 82043 | <1% | 492 | $11.56 | |
| 85652 | <1% | 479 | $9.30 | |
| 82952 | <1% | 126 | $7.84 | |
| 85018 | <1% | 670 | $7.46 | |
| 85046 | <1% | 15 | $5.57 | |
| 85007 | <1% | 502 | $3.80 | |
| 82247 | 0% | 17 | $0.00 | |
| 82977 | 0% | 12 | $0.00 | |
| 82248 | 0% | 40 | $0.00 | |
| 80305 | 0% | 77 | $0.00 | |
| 86787 | 0% | 71 | $0.00 | |
| 80074 | 0% | 125 | $0.00 | |
| 83525 | 0% | 13 | $0.00 | |
| 84112 | 0% | 59 | $0.00 | |
| 86923 | 0% | 22 | $0.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 14 | $0.00 |
| 87641 | 0% | 19 | $0.00 | |
| 80202 | 0% | 24 | $0.00 | |
| 84481 | 0% | 31 | $0.00 | |
| 82803 | 0% | 18 | $0.00 | |
| 83001 | 0% | 31 | $0.00 | |
| 86704 | 0% | 26 | $0.00 | |
| 87088 | 0% | 58 | $0.00 | |
| 86706 | 0% | 40 | $0.00 | |
| 80050 | General health panel | 0% | 44 | $0.00 |
| 86880 | 0% | 12 | $0.00 | |
| 80320 | 0% | 209 | $0.00 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 0% | 73 | $0.00 |
| 87449 | 0% | 12 | $0.00 | |
| 80329 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialESHOA AFFI, CAMELLIA (PRESIDENT)